These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ADVANCE study begins enrollment. AIDS Patient Care STDS; 2008 Apr; 22(4):345. PubMed ID: 18422463 [No Abstract] [Full Text] [Related]
3. [Telaprevir in HCV-monoinfected patients with failure to prior treatment]. Solà R; Forns X Enferm Infecc Microbiol Clin; 2013 Jul; 31 Suppl 3():14-8. PubMed ID: 24063898 [TBL] [Abstract][Full Text] [Related]
4. Prompt arrival of antivirals against hepatitis C for HIV patients. Barreiro P; Vispo E AIDS Rev; 2010; 12(4):242-3. PubMed ID: 21344779 [No Abstract] [Full Text] [Related]
5. [Position paper of the Catalan Society of Gastroenterology: treatment of Genotype 1 Chronic Hepatitis C Virus with Triple Therapy]. Bruguera M; Esteban R; Forns X; Planas R; Quer JC; Solà R; Vergara M; Gastroenterol Hepatol; 2012 Nov; 35(9):667-74. PubMed ID: 22560187 [No Abstract] [Full Text] [Related]
6. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination]. Niederau C MMW Fortschr Med; 2008 Mar; 150(13):26. PubMed ID: 18522352 [No Abstract] [Full Text] [Related]
7. [New triple therapy in chronic hepatitis C. Increased patient chances]. Stiefelhagen P MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830 [No Abstract] [Full Text] [Related]
9. [Treatment for chronic hepatitis C, more opportunity, more challenge]. Wei L Zhonghua Gan Zang Bing Za Zhi; 2009 Jul; 17(7):481-3. PubMed ID: 19912676 [No Abstract] [Full Text] [Related]
10. Phase 3 study results released for telaprevir and HCV. AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535 [No Abstract] [Full Text] [Related]
11. Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials. Kieffer TL; De Meyer S; Bartels DJ; Sullivan JC; Zhang EZ; Tigges A; Dierynck I; Spanks J; Dorrian J; Jiang M; Adiwijaya B; Ghys A; Beumont M; Kauffman RS; Adda N; Jacobson IM; Sherman KE; Zeuzem S; Kwong AD; Picchio G PLoS One; 2012; 7(4):e34372. PubMed ID: 22511937 [TBL] [Abstract][Full Text] [Related]
12. [Clinical use of telaprevir: stopping rules, predicting response, treatment length, and management of adverse effects]. Tural C; Planas R Enferm Infecc Microbiol Clin; 2013 Jul; 31 Suppl 3():19-25. PubMed ID: 24063899 [TBL] [Abstract][Full Text] [Related]
18. Adding telaprevir improves cure rate in patient with HCV infection. AIDS Patient Care STDS; 2010 Dec; 24(12):807. PubMed ID: 21188771 [No Abstract] [Full Text] [Related]
19. [Treatment of hepatitis C infection. A revolution should not hide another]. Sogni P Presse Med; 2014 Apr; 43(4 Pt 1):339-40. PubMed ID: 24661837 [No Abstract] [Full Text] [Related]
20. The dilemma for patients with chronic hepatitis C: treat now or warehouse? Alberti A; Colombo M; Craxì A; Rizzetto M Dig Liver Dis; 2014 Jan; 46(1):27-9. PubMed ID: 24268949 [No Abstract] [Full Text] [Related] [Next] [New Search]